10x Genomics, Inc. with ticker code (TXG) now have 12 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The range between the high target price and low target price is between 68 and 25 suggesting an average Analsyt target price of $57.33. Given that the stocks previous close was at $55.01 this would indicate that there is a potential upside of 4.2%. It’s also worth noting that there is a 50 day moving average of $51.89 and the 200 day MA is $41.14. The company has a market capitalization of 6.47B. The current share price for the company is: 55.67 USD
The potential market cap would be $6,740,602,849 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 4.68 and a -11.04% return on assets.
